glycogen and Hepatic-Veno-Occlusive-Disease

glycogen has been researched along with Hepatic-Veno-Occlusive-Disease* in 1 studies

Other Studies

1 other study(ies) available for glycogen and Hepatic-Veno-Occlusive-Disease

ArticleYear
Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope.
    Folia morphologica, 2004, Volume: 63, Issue:1

    The purpose of the study was to draw upan experimental model of hepatic veno-occlusive disease (VOD) induced by dactinomycin (ACT) and to investigate the possible hepatoprotective effects of Ethyol (amifostine). Pathological changes corresponding to a VOD picture of varying intensification were found in the liver samples obtained from all the rats receiving ACT. Amifostine appears to act protectively to liver changes caused by dactinomycin.

    Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Dactinomycin; Drug Antagonism; Glycogen; Hepatic Veno-Occlusive Disease; Hepatocytes; Injections, Intraperitoneal; Liver; Male; Periodic Acid-Schiff Reaction; Radiation-Protective Agents; Rats; Rats, Wistar

2004